More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

With psoriatic arthritis, one week you may look and feel fine, and then the next week your symptoms may flare. This fluctuation in symptoms makes it difficult to understand whether the pain you ...

Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic ... arthritis including musculoskeletal symptoms (peripheral arthritis, enthesitis, dactylitis and ...

More than one million people are receiving between £28.70 and £184.30 each week through PIP or Adult Disability Payment for ...

Think rheumatoid arthritis only affects the elderly? Or that exercise makes it worse? Time to bust these myths! We got in ...

Arthritis can afflict people from all walks of life, for a plethora of different reasons. Athletes can also develop the ...

Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA ... Improvements in the patients’ assessment of pain and the patients’ ...

Researchers think the combination of substances in willow bark makes it effective in treating headaches, muscle pain ... contains powerful pain-relieving and anti-inflammatory properties. It has been ...

Patients with inflammatory arthritis reported significant loneliness and longed for their doctors to recognize their ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...